Atlanta Dream guard Rhyne Howard tied the WNBA single-game record with nine 3-pointers Friday, becoming the first player in league history to do that more than once. Howard finished with 37 points as ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining cutting-edge genetic engineering with artificial intelligence. The work has ...

CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...

Gene-editing techniques such as CRISPR-Cas9 have many uses in the area of food and agriculture. They can combat persistent drought and disease, and improve the colour and nutritional content of food ...

The Elder Scrolls 6 is without a doubt one of the most anticipated upcoming games, but the problem is that it has now been upcoming for nearly a decade — nearly 14 years if Skyrim's initial launch ...

COALDALE, Pa. — A fire broke out at a home in Schuylkill County on Wednesday evening. Schuylkill County officials say crews were called to the home along East Howard Avenue in Coaldale just before 7 p ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in ...

Overview of CRISPR/Cas system-based tumor molecular diagnostic strategies, including variant gene, protein, and liquid biopsy marker assays and in situ molecular analysis. The CRISPR/Cas system, known ...

UC and Broad have been involved in two interferences at the patent office. Interference No. 106,115 was the second interference between UC and Broad over patent rights to CRISPR-Cas9 technology in ...

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases. KJ Muldoon was born with a rare genetic disorder, ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, co-founder Patrick Hsu, Ph.D., told Fierce Biotech. “Stylus was founded in a ...